Zhejiang Wecome Pharmaceutical Company Limited Stock: price and insider trades · China
维康药业
No insider purchase over the last 90 days. The latest, by 刘忠良, was filed 27 Jan 2022.
Zhejiang Wecome Pharmaceutical Company Limited: what insiders have been doing
Zhejiang Wecome Pharmaceutical Company Limited, classified in the Health Care sector, is a listed company. Its insiders report their share dealings to SSE / SZSE (CSRC). Nothing new has been filed by managers of Zhejiang Wecome Pharmaceutical Company Limited in twelve months, the latest record being from 1 November 2022.
Since 2022, the database holds 1 purchase and 1 sale by insiders of the company.
Elsewhere in the same sector, our signals recently picked up insider purchases at Dynavox Group AB and Vetoquinol SA. These figures are compiled from regulatory filings published by SSE / SZSE (CSRC). They describe what insiders did and are not a recommendation.
Since the insiders bought
- +2.6%Entry CN¥23.41 · Close at T+365 CN¥24.03
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
About Zhejiang Wecome Pharmaceutical Company Limited
维康药业 is a company in the health and pharmaceutical sector, listed on the XSHE market. It focuses on the development and production of innovative medications.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
